Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas: Condition: Malignant Melanoma Interventions: Drug: Fluvastatin; Other: RNA-sequencing; Other: Gene expression profiling Sponsor: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου